Broadwell, R. D., B. J. Balin, and M. Salcman. 1988. Transcytotic pathway
for blood-borne protein through the blood-brain barrier. Proc. Natl. Acad.
Sci. USA 85:632–636.
Broadwell, R. D., and W. A. Banks. 1993. Cell biological perspective for the
transcytosis of peptides and proteins through the mammalian blood-brain
fluid barriers, p. 165–199. In W. M. Pardridge (ed.), The blood-brain barrier.
Raven Press, Ltd., New York, N.Y.
Busso, M., J. Thornthwaite, and L. Resnick. 1991. HIV-induced syncytium
formation requires the formation of conjugates between virus-infected and
uninfected T-cells in vitro. AIDS 5:1425–1432.
Bu ̈ttner, A., P. Mehraein, and S. Weis. 1996. Vascular changes in the cerebral cortex in HIV-1 infection. Acta Neuropathol. 92:35–41.
Elovaara, I., M. Iivanainen, S. L. Valle, J. Suni, T. Tervo, and J. Lahdevirta.
1987. CSF protein and cellular profiles in various stages of HIV infection
related to neurological manifestations. J. Neurol. Sci. 78:331–342.
Falangola, M. F., A. Hanly, B. Galvao-Castro, and C. K. Petito. 1995. HIV
infection of human choroid plexus: a possible mechanism of viral entry into
the CNS. J. Neuropathol. Exp. Neurol. 54:497–503.
Filice, G., P. M. Cereda, and O. E. Varnier. 1988. Infection in rabbits with
human immunodeficiency virus. Nature 335:366–369.
Freed, E. O., and M. A. Martin. 1995. The role of human immunodeficiency
virus type 1 envelope glycoproteins in virus infection. J. Biol. Chem. 270:
23883–23886.
Freed, E. O., and M. A. Martin. 1995. Virion incorporation of envelope
glycoproteins with long but not short cytoplasmi tails is blocked by specific,
single amino acid substitutions in the human immunodeficiency virus type 1
matrix. J. Virol. 69:1984–1989.
Frost, E. H. 1977. Radioactive labelling of viruses: an iodination preserving
biological properties. J. Gen. Virol. 35:181–185.
Gendelman, H. E., J. Zheng, C. L. Coulter, A. Ghorpade, M. Che, M. Thylin,
R. Rubocki, Y. Persidsky, F. Hahn, J. J. Reinhard, and S. Swindells. 1998.
Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J. Infect. Dis.
178:1000–1007.
Gerhart, D. Z., M. A. Broderius, and L. R. Drewes. 1988. Cultured human
and canine endothelial cells from brain microvessels. Brain Res. Bull. 21:
785–793.
Grossman, D. M., W. A. Banks, J. LeBlanc, and P. Dejace. 1998. Prevalence
of hypernatremia in HIV-infected VA patients. J. Investig. Med. 46:46A.
Gutierrez, E. G., W. A. Banks, and A. J. Kastin. 1993. Murine tumor necrosis
factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 47:169–176.
Hall, C. D., C. R. Snyder, K. R. Robertson, J. A. Messenheimer, J. W.
Wilkins, W. T. Robertson, R. A. Whaley, C. Van der Horst, and L. M.
Silverman. 1992. Cerebrospinal fluid analysis in human immunodeficiency
virus infection. Ann. Clin. Lab. Sci. 22:139–143.
Hardebo, J. E., and J. Kahrstrom. 1985. Endothelial negative surface charge
areas and blood-brain barrier function. Acta Physiol. Scand. 125:495–499.
Harouse, J. M., Z. Wroblewska, M. A. Laughlin, W. F. Hickey, B. S. Schonwetter, and F. Gonzalez-Scarano. 1989. Human choroid plexus cells can be
latently infected with human immuodeficiency virus. Ann. Neurol. 25:406–
411.
Harris, P. J. and R. Curry. 1995. Diabetes insipidus and AIDS. J. Acquir.
Immune Defic. Syndr. Hum. Retrovirol. 9:99.
Horan, P. J., A. Mattia, E. J. Bilsky, S. Weber, T. P. Davis, H. I. Yamamura,
E. Malatynska, S. M. Appleyard, J. Slaninova, A. Misicka, A. W. Lipkowski,
V. J. Hruby, and F. Porreca. 1996. Antinociceptive profile of biphalin, a
dimeric enkephalin analog. J. Pharmacol. Exp. Ther. 265:1446–1454.
Hurwitz, A. A., J. W. Berman, and W. D. Lyman. 1994. The role of the
blood-brain barrier in HIV infection of the central nervous system. Adv.
Neuroimmunol. 4:249–256.
Johanson, C. E. 1988. The choroid plexus-arachnoid membrane-cerebrospinal fluid system, p. 33–104. In A. A. Boulton, G. B. Baker, and W. Walz (ed.),
Neuromethods; the neuronal microenvironment. The Humana Press,
Clifton, N.J.
Kage, A., E. Shoolian, K. Rokos, M. Ozel, R. Nuck, W. Reutter, E. Ko ̈ttgen,
and G. Pauli. 1998. Epithelial uptake and transport of cell-free human
immunodeficiency virus type 1 and gp120-coated microparticles. J. Virol.
72:4231–4236.
Koenig, H., J. J. Trout, A. D. Goldstone, and C. Y. Lu. 1992. Capillary
NMDA receptors regulate blood-brain barrier function and breakdown.
Brain Res. 588:297–303.
Lafon, M. E., J. L. Gendrault, C. Royer, D. Jaeck, A. Kirn, and A. M. Steffan.
1993. Human endothelial cells isolated from the hepatic sinusoids and the
umbilical vein display a different permissiveness for HIV-1. Res. Virol.
144:99–104.
Lidinsky, W. A., and L. R. Drewes. 1983. Characterization of the blood-brain
barrier: protein composition of the capillary endothelial cell membrane.
J. Neurochem. 41:1341–1348.
Maness, L. M., W. A. Banks, J. E. Zadina, and A. J. Kastin. 1996. Periventricular penetration and disappearance of icv Tyr-MIF-1, DAMGO, tyrosine,
and albumin. Peptides 17:247–250.
